CAS NO: | 1331782-27-4 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | PF-04995274 is a potent, high-affinity, orally active and partialserotonin 4 receptor (5-HT4R)agonist. PF-04995274 has anEC50range of 0.26-0.47 nM for human5-HT4A/4B/4D/4E(Kirange of 0.15-0.46 nM), and has anEC50range of 0.59-0.65 nM for rat5-HT4S/4L/4E(Kiof 0.30 nM for rat5-HT4S). PF-04995274 is brain penetrant and can be used for cognitive disorders associated with Alzheimer's disease[1][2][3]. | ||||||||||||||||
IC50& Target[1][2][3] |
| ||||||||||||||||
体外研究 (In Vitro) | PF-04995274 hasEC50values of 0.47 nM, 0.36 nM, 0.37 nM, 0.26 nM, 0.59 nM, 0.65 nM and 0.62 nM for human 5-HT4A/4B/4D/4Eand rat 5-HT4S/4L/4E, respectively. PF-04995274 hasKivalues of 0.36 nM, 0.46 nM, 0.15 nM, 0.32 nM and 0.3nM for human 5-HT4A/4B/4D/4Eand rat 5-HT4S, respectively[3]. | ||||||||||||||||
体内研究 (In Vivo) | PF-04995274 (3-10 mg/kg; intravenous injection; for 17 days; male 129S6/SvEv mice) treatment results in prophylactic efficacy by attenuating learned fear and decreasing stress-induced depressive-like behavior[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 432.51 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C23H32N2O6 | ||||||||||||||||
CAS 号 | 1331782-27-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(231.21 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|